148 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Kelsen
    Kelsen
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Panageas
    Panageas
  9. Hensley
    Hensley
  10. Moore
    Moore

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  8. Biostatistics Service (26)
  9. Epidemiology and Biostatistics (26)
  10. Nursing (19)
  1. "recombinant granulocyte colony stimulating factor"
Formats
  1. Journal Article (143)
  2. Conference Paper (5)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Clifford Hudis (19)
  2. Larry Norton (19)
  3. Andrew Seidman (14)
  4. Andrew Zelenetz (12)
  5. Craig Moskowitz (10)
  6. David Kelsen (10)

More People

Years
  1. 2024 (1)
  2. 2015 (2)
  3. 2014 (3)
  4. 2013 (4)
  5. 2012 (5)
  6. 2011 (10)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer (14)
  3. Clinical Breast Cancer (6)
  4. Seminars in Oncology (6)
  5. Blood (5)
  6. Gynecologic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (27)
  3. Wiley Blackwell (16)
  4. Springer (11)
  5. Oxford University Press (9)
  6. Nature Publishing Group (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Lipton, A.; Smith, K. M.; Winston, C. B.; Pfister, D. G.
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Diagnosis and management of lipomatous tumors
    Journal Article

    Dalal, K. M.; Antonescu, C. R.; Singer, S.
    Journal of Surgical Oncology (2008)

    Fulltext@MSK | Save
  • Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Journal Article

    Castro-Malaspina, H.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K.; Chiu, M.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma
    Journal Article

    Shah, G. D.; Yahalom, J.; Correa, D. D.; Lai, R. K.; Raizer, J. J.; Schiff, D.; LaRocca, R.; Grant, B.; Deangelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy
    Journal Article

    Riely, G. J.; Gadgeel, S.; Rothman, I.; Saidman, B.; Sabbath, K.; Feit, K.; Kris, M. G.; Rizvi, N. A.
    Lung Cancer (2007)

    Fulltext@MSK | Save
  • Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Hamlin, P. A.; Gabrilove, J.; Bertino, J. R.; Portlock, C. S.; Straus, D. J.; Gencarelli, A. N.; Nimer, S. D.; Zelenetz, A. D.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: Potential consequences of granulocyte-colony-stimulating factor administration
    Journal Article

    Morales-Arias, J.; Meyers, P. A.; Bolontrade, M. F.; Rodriguez, N.; Zhou, Z.; Reddy, K.; Chou, A. J.; Koshkina, N. V.; Kleinerman, E. S.
    Cancer (2007)

    Fulltext@MSK | Save
  • Dose-dense therapy in the treatment of early-stage breast cancer: An overview of the data
    Journal Article

    Mcarthur, H. L.; Hudis, C. A.
    Clinical Breast Cancer (2007)

    Fulltext@MSK | Save